ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ICUI ICU Medical Inc

107.32
4.43 (4.31%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 348,272
Bid Price 100.43
Ask Price 110.79
News -
Day High 108.235

Low
78.28

52 Week Range

High
212.43

Day Low 102.74
Company Name Stock Ticker Symbol Market Type
ICU Medical Inc ICUI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
4.43 4.31% 107.32 20:00:00
Open Price Low Price High Price Close Price Prev Close
103.05 102.74 108.235 107.32 102.89
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9,270 348,272 $ 106.96 $ 37,252,911 - 78.28 - 212.43
Last Trade Time Type Quantity Stock Price Currency
18:26:21 44 $ 107.25 USD

ICU Medical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.59B 24.14M - 2.28B -29.66M -1.23 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ICU Medical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ICUI Message Board. Create One! See More Posts on ICUI Message Board See More Message Board Posts

Historical ICUI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week97.32108.23595.3399.69232,08610.0010.28%
1 Month114.39114.3995.33102.22280,239-7.07-6.18%
3 Months95.20123.4686.8099.91263,76412.1212.73%
6 Months116.84123.4678.2895.52319,081-9.52-8.15%
1 Year156.46212.4378.28121.83254,369-49.14-31.41%
3 Years209.43282.0078.28164.43202,218-102.11-48.76%
5 Years235.20282.0078.28175.79188,995-127.88-54.37%

ICU Medical Description

ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICU's acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically.

Your Recent History

Delayed Upgrade Clock